FONAR (FONR) Competitors $15.10 +0.13 (+0.87%) (As of 01:48 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends FONR vs. ZIMV, DCTH, NPCE, RCEL, SMTI, CVRX, ZYXI, ELMD, LUNG, and CATXShould you be buying FONAR stock or one of its competitors? The main competitors of FONAR include ZimVie (ZIMV), Delcath Systems (DCTH), NeuroPace (NPCE), AVITA Medical (RCEL), Sanara MedTech (SMTI), CVRx (CVRX), Zynex (ZYXI), Electromed (ELMD), Pulmonx (LUNG), and Perspective Therapeutics (CATX). These companies are all part of the "medical equipment" industry. FONAR vs. ZimVie Delcath Systems NeuroPace AVITA Medical Sanara MedTech CVRx Zynex Electromed Pulmonx Perspective Therapeutics ZimVie (NASDAQ:ZIMV) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk. Which has more volatility and risk, ZIMV or FONR? ZimVie has a beta of 2.12, meaning that its stock price is 112% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Does the MarketBeat Community prefer ZIMV or FONR? FONAR received 177 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 18.75% of users gave ZimVie an outperform vote. CompanyUnderperformOutperformZimVieOutperform Votes318.75%Underperform Votes1381.25% FONAROutperform Votes18074.69% Underperform Votes6125.31% Do insiders & institutionals believe in ZIMV or FONR? 95.6% of ZimVie shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 3.0% of ZimVie shares are held by company insiders. Comparatively, 2.2% of FONAR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is ZIMV or FONR more profitable? FONAR has a net margin of 9.41% compared to ZimVie's net margin of -77.31%. FONAR's return on equity of 6.10% beat ZimVie's return on equity.Company Net Margins Return on Equity Return on Assets ZimVie-77.31% 2.90% 1.17% FONAR 9.41%6.10%4.58% Do analysts recommend ZIMV or FONR? ZimVie currently has a consensus price target of $19.50, suggesting a potential upside of 40.79%. Given ZimVie's stronger consensus rating and higher possible upside, equities research analysts clearly believe ZimVie is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ZimVie 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer ZIMV or FONR? In the previous week, ZimVie's average media sentiment score of 0.00 equaled FONAR'saverage media sentiment score. Company Overall Sentiment ZimVie Neutral FONAR Neutral Which has higher valuation and earnings, ZIMV or FONR? FONAR has lower revenue, but higher earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimVie$451.29M0.85-$393.28M-$13.11-1.06FONAR$102.01M0.94$10.57M$1.4010.79 SummaryFONAR beats ZimVie on 9 of the 16 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get FONAR News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFONARElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$95.55M$3.09B$5.22B$9.27BDividend YieldN/A1.77%5.12%4.29%P/E Ratio10.7917.3787.4217.27Price / Sales0.9451.831,166.39119.60Price / Cash5.0639.9343.2337.83Price / Book0.613.814.834.93Net Income$10.57M$89.83M$120.46M$225.34M7 Day Performance-1.24%2.70%-0.26%1.13%1 Month Performance-8.15%0.79%15.99%2.76%1 Year Performance-24.08%2.11%30.22%16.90% FONAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFONARN/A$15.10+0.9%N/A-24.7%$95.55M$102.01M10.79480ZIMVZimVie2.4288 of 5 stars$13.62+0.1%$19.50+43.2%-23.6%$375.90M$451.29M-1.042,600DCTHDelcath Systems2.8725 of 5 stars$11.19+1.6%$21.50+92.1%+185.3%$357.79M$22.64M-8.2976NPCENeuroPace3.8168 of 5 stars$11.50-0.3%$14.50+26.1%+26.1%$343.25M$76.45M-11.50170RCELAVITA Medical1.8218 of 5 stars$11.84+0.6%$16.50+39.4%-11.3%$310.42M$60.04M-5.31130Analyst ForecastNews CoverageGap UpSMTISanara MedTech2.2994 of 5 stars$34.60+2.7%$47.00+35.8%-10.9%$302.44M$78.06M-34.9560Analyst ForecastNews CoverageGap UpCVRXCVRx3.6818 of 5 stars$12.40+2.4%$16.67+34.4%-50.0%$300.87M$47.26M-4.59200Positive NewsZYXIZynex3.5554 of 5 stars$8.15-1.2%$14.00+71.8%-22.7%$259.55M$193.67M54.331,100ELMDElectromedN/A$29.32+5.7%N/A+169.3%$247.99M$57.06M40.72174High Trading VolumeLUNGPulmonx2.7409 of 5 stars$6.19+0.7%$12.75+106.0%-50.7%$244.43M$79.30M-4.21250CATXPerspective Therapeutics3.4319 of 5 stars$3.19+11.9%$15.14+374.7%N/A$215.61M$1.43M0.00116Positive News Related Companies and Tools Related Companies ZimVie Competitors Delcath Systems Competitors NeuroPace Competitors AVITA Medical Competitors Sanara MedTech Competitors CVRx Competitors Zynex Competitors Electromed Competitors Pulmonx Competitors Perspective Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FONR) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FONAR Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share FONAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FONR Stock Alerts